The only biotech with an active hESC-based clinical trial, Advanced Cell Technology (ACT) will have three top leaders including CEO Gary Rabin participating in a CIRM webinar on stem cell-based treatments for eye disorders this Wednesday. Also involved with be Samuel Barone, a medical officer from the FDA.
You don’t want to miss this one!
Register here (required in advance!)
I think CIRM and ACT joining forces on this is a great development.
(Hat tip to David Jensen, who posted on this yesterday)